MERIT CRO Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • MERIT CRO's estimated annual revenue is currently $19.1M per year.(i)
  • MERIT CRO's estimated revenue per employee is $151,310

Employee Data

  • MERIT CRO has 126 Employees.(i)
  • MERIT CRO grew their employee count by 26% last year.

MERIT CRO's People

NameTitleEmail/Phone
1
Co-Founder & Chief Scientific OfficerReveal Email/Phone
2
Chief Operating OfficerReveal Email/Phone
3
CEOReveal Email/Phone
4
Chief Development OfficerReveal Email/Phone
5
Chief Development Officer, OphthalmologyReveal Email/Phone
6
VP, Medical and Scientific AffairsReveal Email/Phone
7
VP Clinical ServicesReveal Email/Phone
8
VP Product DevelopmentReveal Email/Phone
9
ControllerReveal Email/Phone
10
VP OncologyReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is MERIT CRO?

keywords:N/A

N/A

Total Funding

126

Number of Employees

$19.1M

Revenue (est)

26%

Employee Growth %

N/A

Valuation

N/A

Accelerator

MERIT CRO News

2022-04-19 - Cosmos: A Look At 'The Internet Of Blockchains'

... are Terra (LUNA-USD) and Crypto.com's native token Cronos (CRO-USD). ... Though I believe the Cosmos ecosystem itself has some merit,...

2021-04-05 - EyeKor Announces New Brand Identity, MERIT CRO

MADISON, Wis., April 5, 2021 /PRNewswire/ -- EyeKor, Inc., an innovative Contract Research Organization (CRO) specializing in medical imaging and data management for clinical studies, announced today the company will rebrand as MERIT CRO. The new brand identity follows the company's recent acq ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$17.8M1266%N/A
#2
$25.3M12610%N/A
#3
$15M12617%N/A
#4
$22.7M1265%N/A
#5
$12.5M12654%N/A